Telo Genomics Corp.
TELO.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.32% | 2.94% | 15.01% | 23.97% | 10.67% |
| Total Depreciation and Amortization | -67.06% | -64.38% | -51.64% | -32.89% | -7.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,172.12% | 465.31% | 24.21% | -125.36% | -89.87% |
| Change in Net Operating Assets | -32.43% | -66.84% | -70.75% | 215.26% | 472.32% |
| Cash from Operations | 6.72% | 8.69% | 12.99% | 28.66% | 20.34% |
| Capital Expenditure | -123.53% | 39.47% | -37.93% | 92.80% | 94.20% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -123.53% | 39.47% | -37.93% | 92.80% | 94.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -200.00% | -200.00% |
| Issuance of Common Stock | 291.68% | 291.68% | 12.77% | 12.77% | -77.54% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -474.22% | -444.94% | -23.40% | -23.16% | 81.70% |
| Cash from Financing | 286.08% | 287.50% | 9.18% | 7.40% | -78.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 110.14% | 100.01% | 2,124.75% | 880.76% | -1,092.25% |